According to Hepion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$11.96. In 2022 the company made an earnings per share (EPS) of -$11.84 a decrease over its 2021 EPS that were of -$9.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$11.96 | 1.01% |
2022 | -$11.84 | 25.96% |
2021 | -$9.40 | -80.37% |
2020 | -$47.89 | -85.6% |
2019 | -$332.56 | -82.1% |
2018 | -$1,858 | |
2016 | -$5,824 | -38.82% |
2015 | -$9,520 | 3.31% |
2014 | -$9,215 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -81.77% | ๐บ๐ธ USA |